Should healthcare be free and publicly funded?

Welcome to the debate arena! Today's topic: "Should healthcare be free and publicly funded?". Your opponent's style: Donald trump

Free healthcare isn't about ideology—it's about math. When you pool resources nationally, administrative costs plummet and negotiating power explodes. Every other developed nation proved this works. The real question isn't whether we can afford it. It's whether we can afford NOT to, watching people ration insulin while we bankroll pharmaceutical profits.

You're confusing correlation with causation. Yes, other nations spend less per capita, but they also ration care ruthlessly, impose brutal wait times, and innovate at a fraction of America's rate. We've funded 60% of global pharmaceutical breakthroughs. Strip that incentive through price controls and negotiating monopsonies, you don't get efficiency—you get stagnation. So here's the real math: how many life-saving drugs never get invented when profit disappears?

You're flipping the causation backward. Americans pay twice what Germans pay for the same insulin—not because we're funding innovation, but because we're funding shareholder dividends. Germany still invents drugs. Britain still invents drugs. Canada still invests in pharma research without bankrupting diabetics. Your argument assumes profit is the only incentive for innovation, but scientists don't discover cures for stock options. They discover them because the work matters. We can negotiate prices AND fund research. Other nations do it constantly. We just choose not to.

You're cherry-picking one drug and ignoring the pipeline. Germany innovates, yes—but trails America 4-to-1 in new molecular entities. Britain and Canada? They free-ride on American R&D, then undercut prices once drugs exist. Scientists care about the work; executives fund labs because investors demand returns. Your "we can do both" assumes magic—price controls in America don't just lower costs, they eviscerate capital for the next round of research. Name one country that negotiates hard AND leads innovation.

I can name one Germany are waiting times long yes however the amount of people that need insulin but can't have it is disgraceful in the untied states it's up to 200$ for insulin where its 50-100 in Germany. Not to mention on your point of other countries drug output Germany produces 90 billion pharmological output per year.

You're conflating two separate problems. Yes, insulin pricing is obscene—that's a monopoly and patent abuse issue, not proof that public systems work better overall. Germany's pharma output means nothing if it's generic manufacturing, not innovation. America produces those breakthroughs Germany then copies at lower cost. Fix patent law and drug pricing specifically instead of torching the entire system. Why haven't you addressed the pipeline problem? What incentivizes the next insulin if margins vanish?

You just admitted the system is broken—then argued we should keep it. If patent law and pricing are the real problems, why hasn't Congress fixed them in twenty years? They won't, because pharma lobbies block it. Public systems don't have that problem because they're not for sale. Germany negotiates directly, no middlemen bleeding margins. And margins aren't disappearing—they're just smaller. Insulin still gets made because it saves lives, not because shareholders get yachts. You're asking me to fix a corrupt system instead of replacing it. That's not a counterargument, that's surrender.

Congress won't fix it because the problem is political cowardice, not capitalism's fault—Democrats and Republicans both kowtow to unions and provider lobbies, not just pharma. Germany negotiates prices down, yes, then waits six months for MRIs while Americans get them in weeks. You're trading one corruption (corporate) for another (bureaucratic), pretending the second doesn't exist. If public systems are incorruptible, why do NHS executives systematize rationing? Which corruption would you rather suffer from?

You're equating apples and grenades. Yes, bureaucratic rationing exists—but it rations based on medical need, not ability to pay. An MRI wait in Germany doesn't kill you; an American who skips insulin because it costs $300 dies. You're saying "pick your poison" when I'm saying one poison is survivable and the other isn't. Britain's NHS waits six months for non-urgent scans. Americans wait forever for care they can't afford. That's not a choice between two corruptions—it's a choice between inconvenience and death.

You're romanticizing rationing as noble when it's just invisible. A diabetic who waits four months for an endocrinologist appointment while their complications worsen isn't "inconvenienced"—they're dying slower. America's problem isn't the system, it's that 40% of costs go to government programs that already price-control ruthlessly. You want full nationalization to fix partial nationalization's failures. Why would adding more bureaucracy solve what bureaucracy already broke?

You're inverting the problem. America's bureaucracy doesn't fix things—it extracts profit. Medicare already negotiates drug prices successfully, yet Americans still pay triple what other countries do for identical medications. The difference isn't bureaucracy versus markets; it's bureaucracy serving patients versus serving shareholders. A four-month endocrinologist wait is real. An American rationing insulin until they go blind is also real—and it's happening now, not in some hypothetical. You're defending the devil we have while calling the alternative imaginary.

Medicare negotiates badly because Congress hobbles it with political carrots for providers. You're not comparing real systems—you're comparing America's hybrid mess against other nations' best-case marketing. Show me the British cancer survival rates versus ours. Show me German innovation without American-funded trials. You keep citing insulin while ignoring the 300,000 Americans alive today because they got experimental drugs Congress would never fund under your system. Which deaths matter more?